These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of seat surface inclination on postural control during reaching in preterm children with cerebral palsy. Hadders-Algra M, van der Heide JC, Fock JM, Stremmelaar E, van Eykern LA, Otten B. Phys Ther; 2007 Jul; 87(7):861-71. PubMed ID: 17472949 [Abstract] [Full Text] [Related]
7. Effect of selective dorsal rhizotomy on need for orthopedic surgery for spastic quadriplegic cerebral palsy: long-term outcome analysis in relation to age. O'Brien DF, Park TS, Puglisi JA, Collins DR, Leuthardt EC. J Neurosurg; 2004 Aug 15; 101(1 Suppl):59-63. PubMed ID: 16206973 [Abstract] [Full Text] [Related]
8. Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Shevell MI, Dagenais L, Hall N, REPACQ Consortium. Neurology; 2009 Jun 16; 72(24):2090-6. PubMed ID: 19528515 [Abstract] [Full Text] [Related]
9. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease. Goberman AM. Med Sci Monit; 2005 Mar 16; 11(3):CR109-16. PubMed ID: 15735562 [Abstract] [Full Text] [Related]
10. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Arch Phys Med Rehabil; 2006 Jan 16; 87(1):141-4. PubMed ID: 16401453 [Abstract] [Full Text] [Related]
13. Longitudinal study of the motor response to levodopa in Parkinson's disease. Clissold BG, McColl CD, Reardon KR, Shiff M, Kempster PA. Mov Disord; 2006 Dec 16; 21(12):2116-21. PubMed ID: 17029259 [Abstract] [Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of levodopa. Nutt JG. Mov Disord; 2008 Dec 16; 23 Suppl 3():S580-4. PubMed ID: 18781675 [Abstract] [Full Text] [Related]
15. The effects of therapeutic taping on gross motor function in children with cerebral palsy. Footer CB. Pediatr Phys Ther; 2006 Dec 16; 18(4):245-52. PubMed ID: 17108797 [Abstract] [Full Text] [Related]
16. Levodopa affects functional brain networks in Parkinsonian resting tremor. Pollok B, Makhloufi H, Butz M, Gross J, Timmermann L, Wojtecki L, Schnitzler A. Mov Disord; 2009 Jan 15; 24(1):91-8. PubMed ID: 18823037 [Abstract] [Full Text] [Related]
18. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. Hironishi M, Miwa H, Kondo T. No To Shinkei; 2002 Feb 15; 54(2):127-32. PubMed ID: 11889758 [Abstract] [Full Text] [Related]
19. [Findings on magnetic resonance in spastic cerebral palsy]. Ramos J, Belmonte MJ, Cassinello E. Rev Neurol; 2002 Feb 15; 32(10):908-15. PubMed ID: 11424044 [Abstract] [Full Text] [Related]